410 related articles for article (PubMed ID: 27029486)
21. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis by inhibiting intestinal epithelial apoptosis.
Zhu T; Liu TJ; Shi YY; Zhao Q
Int J Mol Med; 2015 May; 35(5):1213-8. PubMed ID: 25813397
[TBL] [Abstract][Full Text] [Related]
22. miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's disease.
Cheng X; Zhang X; Su J; Zhang Y; Zhou W; Zhou J; Wang C; Liang H; Chen X; Shi R; Zen K; Zhang CY; Zhang H
Sci Rep; 2015 May; 5():10397. PubMed ID: 25997679
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-146a-5p attenuates visceral hypersensitivity through targeting chemokine CCL8 in the spinal cord in a mouse model of colitis.
Lu Y; Cao DL; Zhao LX; Han Y; Zhang YL
Brain Res Bull; 2018 May; 139():235-242. PubMed ID: 29550454
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases.
Clark PM; Dawany N; Dampier W; Byers SW; Pestell RG; Tozeren A
Inflamm Bowel Dis; 2012 Dec; 18(12):2315-33. PubMed ID: 22488912
[TBL] [Abstract][Full Text] [Related]
25. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
26. The guanylate cyclase-C signaling pathway is down-regulated in inflammatory bowel disease.
Brenna Ø; Bruland T; Furnes MW; Granlund Av; Drozdov I; Emgård J; Brønstad G; Kidd M; Sandvik AK; Gustafsson BI
Scand J Gastroenterol; 2015; 50(10):1241-52. PubMed ID: 25979109
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
28. The IL23 axis plays a key role in the pathogenesis of IBD.
McGovern D; Powrie F
Gut; 2007 Oct; 56(10):1333-6. PubMed ID: 17872562
[TBL] [Abstract][Full Text] [Related]
29. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
30. miR-340 affects sauchinone inhibition of Th17 cell differentiation and promotes intestinal inflammation in inflammatory bowel disease.
Chen Q; He Q; Xiu W; Chen Y; Guo Z
Biochem Biophys Res Commun; 2020 Jun; 526(4):1157-1163. PubMed ID: 32321642
[TBL] [Abstract][Full Text] [Related]
31. Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?
Te Velde AA; Pronk I; de Kort F; Stokkers PC
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):555-60. PubMed ID: 18467915
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
33. IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant.
Sun R; Abraham C
Cell Mol Gastroenterol Hepatol; 2020; 10(4):673-697. PubMed ID: 32474165
[TBL] [Abstract][Full Text] [Related]
34. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease.
Soroosh A; Koutsioumpa M; Pothoulakis C; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G256-G262. PubMed ID: 29146677
[TBL] [Abstract][Full Text] [Related]
35. Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD).
Gadaleta RM; Garcia-Irigoyen O; Moschetta A
Curr Protoc Mouse Biol; 2017 Mar; 7(1):13-28. PubMed ID: 28252200
[TBL] [Abstract][Full Text] [Related]
36. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
[TBL] [Abstract][Full Text] [Related]
37. MiR-155 inhibition ameliorates 2, 4, 6-Trinitrobenzenesulfonic acid (TNBS)-induced experimental colitis in rat via influencing the differentiation of Th17 cells by Jarid2.
Liu Y; Dong Y; Zhu X; Fan H; Xu M; Chen Q; Nan Z; Wu H; Deng S; Liu X; Zuo D; Yang J
Int Immunopharmacol; 2018 Nov; 64():401-410. PubMed ID: 30253332
[TBL] [Abstract][Full Text] [Related]
38. miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea.
Martínez C; Rodiño-Janeiro BK; Lobo B; Stanifer ML; Klaus B; Granzow M; González-Castro AM; Salvo-Romero E; Alonso-Cotoner C; Pigrau M; Roeth R; Rappold G; Huber W; González-Silos R; Lorenzo J; de Torres I; Azpiroz F; Boulant S; Vicario M; Niesler B; Santos J
Gut; 2017 Sep; 66(9):1537-1538. PubMed ID: 28082316
[TBL] [Abstract][Full Text] [Related]
39. Role of MiRNAs in Inflammatory Bowel Disease.
Cao B; Zhou X; Ma J; Zhou W; Yang W; Fan D; Hong L
Dig Dis Sci; 2017 Jun; 62(6):1426-1438. PubMed ID: 28391412
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.
Ge Y; Sun M; Wu W; Ma C; Zhang C; He C; Li J; Cong Y; Zhang D; Liu Z
J Autoimmun; 2019 Jul; 101():109-120. PubMed ID: 31014918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
